Docoh
Loading...

40 results

Filter options loading...
Top filers
Top filing types
Recent filing years
424B5
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Prospectus supplement for primary offering
4:46pm
products targeted to patients who have an unmet medical need. Although we believe that the skills and experience of our team members in drug development
10-Q
2021 Q2
PCSA Processa Pharmaceuticals Inc
12 Aug 21
Quarterly report
4:01pm
that the skills and experience of our team members in drug development and commercialization is an important indicator of our future success, the past
10-Q
2021 Q1
PCSA Processa Pharmaceuticals Inc
13 May 21
Quarterly report
4:30pm
to patients who have an unmet medical need. Although we believe that the skills and experience of our team members in drug development and commercialization
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
for which such nominee serves or has served as a director during such period, and the experience, qualifications, attributes or skills that has led
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
than 50 drug development programs, including drug products targeted to patients who have an unmet medical need. Although we believe that the skills
10-Q
2020 Q3
PCSA Processa Pharmaceuticals Inc
12 Nov 20
Quarterly report
4:01pm
that the skills and experience of our team in drug development and commercialization is an important indicator of our future success, the past successes
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
a unique set of skills, abilities, and experiences which will benefit Processa, and he agrees that his continued employment with Processa, whether
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
that the skills and experience of our team in drug development and commercialization is an important indicator of our future success, the past
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
who have an unmet medical need. Although we believe that the skills and experience of our team in drug development and commercialization
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
targeted to patients who have an unmet medical need. Although we believe that the skills and experience of our team in drug development
S-1/A
EX-10.4
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
with the understanding that the Employee possesses a unique set of skills, abilities, and experiences which will benefit Processa, and he agrees
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
that the skills and experience of our team in drug development and commercialization is an important indicator of our future success, the past successes of our
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
to patients who have an unmet medical need. Although we believe that the skills and experience of our team in drug development and commercialization
8-K
EX-99.1
PCSA Processa Pharmaceuticals Inc
13 Feb 20
Processa Pharmaceuticals Appoints
9:30am
of Processa’s evolution. Her strong investment and finance skills as well as leadership experience will complement our existing board,” said Dr. David Young
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
targeted to patients who have an unmet medical need.Although we believe that the skills and experience of our team in drug development
DEF 14A
PCSA Processa Pharmaceuticals Inc
26 Apr 19
Definitive proxy
5:02pm
for which such nominee serves or has served as a director during such period, and the experience, qualifications, attributes or skills that has led … is to always have a Board of Directors that brings us a variety of perspectives and skills derived from high quality business, professional
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
we believe that the skills and experience of our team in drug development and commercialization is an important indicator of our future success
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
we believe that the skills and experience of our team in drug development and commercialization is an important indicator of our future success
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
believe that the skills and experience of our team in drug development and commercialization is an important indicator of our future success, the past … to the particular talents and experience of our directors; The knowledge, skills and experience of nominees; Experience with accounting rules
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
to patients who have an unmet medical need.Although we believe that the skills and experience of our team in drug development and commercialization … : The appropriate size of the Board; Our needs with respect to the particular talents and experience of our directors; The knowledge, skills and experience